Name: SILICA PILLARED MAGNETIC CLAY NANOCOMPOSITES and DRUG RELEASE (en Inglés)
Price: 1620.40 MXN
Availability: InStock
Author: Çiftçi, Hakan
ISBN: 9786202530002

Envío gratis

portada SILICA PILLARED MAGNETIC CLAY NANOCOMPOSITES and DRUG RELEASE (en Inglés)

Formato

Libro Físico

Autor

Hakan Çiftçi

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

160

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.9 cm

Peso

0.24 kg.

ISBN13

9786202530002

Categorías

Química

SILICA PILLARED MAGNETIC CLAY NANOCOMPOSITES and DRUG RELEASE (en Inglés)

Hakan Çiftçi (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo

$ 1,620.40

$ 2,946.18

Ahorras: $ 1,325.78

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 05 de Agosto y el Viernes 16 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "SILICA PILLARED MAGNETIC CLAY NANOCOMPOSITES and DRUG RELEASE (en Inglés)"

This book contains scientific investigations which focused on developing of mesoporous, magnetic, and silica pillared nanocomposites (NCs) to encapsulate the active ingredients used for the successful treatment of various diseases, and to deliver them to targeted areas. In this context, two different raw Mt clay ores were first purified using mineral beneficiation techniques such as sedimentation, flotation, and centrifuge effected gravity seperation. After the clay beneficiation studies, NCs were prepared as a function of TEOS and CTAB concentrations. Two main goals were aimed in NCs production. The first one was the production of NCs with magnetic sensitivity. The second one was to obtain the mesoporous structure to achieve controlled drug release performance. The surface of the NCs prepared under optimum conditions was also modified with aminopropyltriethoxysilane (APTES) to produce a second formulation. Finally, the loading and in vitro release performances of 5-Fluorouracil active ingredient from NCs produced under optimum conditions as a drug delivery system were investigated.